Topical glucocorticoid has no antinociceptive or anti-inflammatory effect in thermal injury.

We have studied the antinociceptive and anti-inflammatory effects of topical glucocorticoids in human thermal injury. The right and left legs of 12 healthy volunteers were allocated randomly to be treated with either 0.05% clobetasol propionate cream or placebo in a double-blind trial. Thermal injuries were induced with a thermode, which was heated to 49 degrees C for 5 min under standardized pressure. Clobetasol propionate or placebo cream was applied to the skin 1 h before burn injury, immediately after the injury and every 12 h for the next 3 days. Heat pain detection thresholds (HPDT), heat pain tolerance (HPT), mechanical pain detection thresholds (MPDT) and the intensity of burn-induced erythema (erythema index, EI) were assessed inside the thermal injury and areas of hyperalgesia to pinprick outside the injury were determined before and regularly for 72 h after the burn injury. Burn injury caused a decrease in HPDT, HPT and MPDT, an increase in EI and development of mechanical, secondary hyperalgesia. Clobetasol propionate had no effect on any of the nociceptive or inflammatory variables studied.

[1]  H. Kehlet,et al.  Time course of primary and secondary hyperalgesia after heat injury to the skin. , 1993, British journal of anaesthesia.

[2]  L. Arendt-Nielsen,et al.  The effect of pre- versus postinjury infiltration with lidocaine on thermal and mechanical hyperalgesia after heat injury to the skin , 1993, Pain.

[3]  A. Dray,et al.  Bradykinin and inflammatory pain , 1993, Trends in Neurosciences.

[4]  James N. Campbell,et al.  Peripheral and central mechanisms of cutaneous hyperalgesia , 1992, Progress in Neurobiology.

[5]  C. Woolf Central mechanisms of acute pain , 1990, Pain.

[6]  T. Kupper Immune and inflammatory processes in cutaneous tissues. Mechanisms and speculations. , 1990, The Journal of clinical investigation.

[7]  K. Hargreaves,et al.  Glucocorticoids suppress levels of immunoreactive bradykinin in inflamed tissue as evaluated by microdialysis probes , 1990, Clinical pharmacology and therapeutics.

[8]  R. Meyer,et al.  Peripheral Mechanisms of Somatic Pain , 1988, Anesthesiology.

[9]  K. Matsushima,et al.  Analysis of the suppression of IL-1 alpha and IL-1 beta production in human peripheral blood mononuclear adherent cells by a glucocorticoid hormone. , 1988, Journal of immunology.

[10]  R. Naclerio,et al.  Inhibition of mediator release in allergic rhinitis by pretreatment with topical glucocorticosteroids. , 1987, The New England journal of medicine.

[11]  P. Bjerring,et al.  Skin reflectance spectrophotometry. , 1987, Photo-dermatology.

[12]  T. Hindson,et al.  CLOBETASOL PROPIONATE OINTMENT AS FIRST-AID FOR BURNS , 1987, The Lancet.

[13]  B. Beutler,et al.  Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. , 1986, Science.

[14]  T. Hindson,et al.  Clobetasol propionate ointment reduces inflammation after cryotherapy , 1985, The British journal of dermatology.

[15]  R. Flower,et al.  Hydrocortisone and 'macrocortin' inhibit the zymosan-induced release of lyso-PAF from rat peritoneal leucocytes. , 1985, Life sciences.

[16]  Ö. Hägermark,et al.  Effects of topically applied clobetasol-17-propionate on histamine release in human skin. , 1984, Acta dermato-venereologica.

[17]  A. Calin Pain and inflammation , 1981, PAIN.

[18]  R. Schleimer,et al.  Inhibition of basophil histamine release by anti-inflammatory steroids , 1981, Nature.

[19]  M. Robson,et al.  The effect of prostaglandins on the dermal microcirculation after burning, and the inhibition of the effect by specific pharmacological agents. , 1979, Plastic and reconstructive surgery.

[20]  R. Bronaugh,et al.  The evaluation of topical anti-inflammatory activity on rat ears subjected to thermal injury. , 1978, The Journal of investigative dermatology.

[21]  M. Robson,et al.  Prevention of dermal ischemia after thermal injury. , 1978, Archives of surgery.